1-7 of 7
Andrew R. Crow, BSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Amelioration of Immune Thrombocytopenia in Human CD44 Transgenic Mice By Anti-Human CD44 Antibodies

Andrew R. Crow, BSc, Alaa Amash, PhD, Alan H Lazarus, PhD
Journal: Blood
Blood (2016) 128 (22): 167.
https://doi.org/10.1182/blood.V128.22.167.167
Published: 2016
Journal Articles

Ivig, but Not a Monoclonal Anti-RBC Antibody, Requires the Presence of Gr-1 + Cells to Ameliorate Immune Thrombocytopenia in a Murine Model

Andrew R. Crow, BSc, Alan H Lazarus, PhD
Journal: Blood
Blood (2012) 120 (21): 268.
https://doi.org/10.1182/blood.V120.21.268.268
Published: 2012
Journal Articles

CD44 Antibody Mediated Amelioration of Murine ITP: Evidence for a Similar Strain Dependent FcγRIIB Requirement As Compared to Ivig

Andrew R. Crow, BSc, Alan H Lazarus, PhD
Journal: Blood
Blood (2012) 120 (21): 1084.
https://doi.org/10.1182/blood.V120.21.1084.1084
Published: 2012
Journal Articles

IVIg-Primed Leukocytes Offer Longer Protection in the Amelioration of ITP Than IVIg.

Andrew R. Crow, BSc, Davor Brinc, BSc, Vinayakumar Siragam, PhD, John Freedman, MD, Alan H. Lazarus, PhD
Journal: Blood
Blood (2006) 108 (11): 703.
https://doi.org/10.1182/blood.V108.11.703.703
Published: 2006
Journal Articles

Inhibition of Immune Thrombocytopenic Purpura (ITP) by an Orally Bioavailable Inhibitor of Syk Kinase Activity.

Andrew R. Crow, BSc, Vinayakumar Siragam, PhD, John Freedman, MD, Elliott B. Grossbard, MD, Esteban S. Masuda, PhD, Polly Pine, PhD, Alan H. Lazarus, PhD
Journal: Blood
Blood (2005) 106 (11): 2165.
https://doi.org/10.1182/blood.V106.11.2165.2165
Published: 2005
Journal Articles

A Role for IL-1Receptor Antagonist in the Acute Therapeutic Effects of IVIg?.

Andrew R. Crow, BSc, Seng Song, MD, John Freedman, MD, John W. Semple, PhD, Alan H. Lazarus, PhD
Journal: Blood
Blood (2004) 104 (11): 2064.
https://doi.org/10.1182/blood.V104.11.2064.2064
Published: 2004
Journal Articles

Can IVIg Preparations with Specificity for Soluble Antigens Mimic the Therapeutic Effects of IVIg in the Treatment of Immune Thrombocytopenia?.

Vinayakumar Siragam, PhD, Davor Brinc, BSc, Andrew R. Crow, BSc, Seng Song, MD, John Freedman, MD, Alan H. Lazarus, PhD.
Journal: Blood
Blood (2004) 104 (11): 2073.
https://doi.org/10.1182/blood.V104.11.2073.2073
Published: 2004